We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+16.51%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$1.93B
AUM Growth
-$485M
(-20%)
Cap. Flow
-$562M
Cap. Flow
% of AUM
-29.17%
Top 10 Holdings %
Top 10 Hldgs %
5.51%
Holding
3,496
New
1,220
Increased
551
Reduced
717
Closed
1,006
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$10.4M |
| 2 |
Cisco
CSCO
|
+$7.97M |
| 3 |
American Tower
AMT
|
+$7.79M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$7.33M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$16.2M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$15.1M |
| 3 |
Amazon
AMZN
|
+$13.7M |
| 4 |
Philip Morris
PM
|
+$13.5M |
| 5 |
Amphenol
APH
|
+$12.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14% |
| 3 | Healthcare | 12.51% |
| 4 | Consumer Discretionary | 11.31% |
| 5 | Industrials | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
MIRA Pharmaceuticals
MIRA
$35.3M
| $48.9K | ﹤0.01% |
35,923
+14,050
| +64% | +$20.4K |
|
2177
ALX Oncology
ALXO
$268M
| $48.7K | ﹤0.01% |
26,621
-48,149
| -64% | -$41.7K |
|
2178
Greenland Technologies Holding
GTEC
$14M
| $48.4K | ﹤0.01% |
+36,648
| New | +$56.9K |
|
|
VIP
2179
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$38.1M
| $48.3K | ﹤0.01% |
26,512
-5,629
| -18% | -$8.73K |
|
|
LGO
2180
Largo
LGO
$60.5M
| $48.2K | ﹤0.01% |
32,130
-2,990
| -9% | -$4.49K |
|
|
SLAI
2181
DELISTED
SOLAI Ltd ADS
SLAI
| $48K | ﹤0.01% |
+2,539
| New | +$53.1K |
|
|
ANEB
2182
DELISTED
Anebulo Pharmaceuticals
ANEB
| $47.9K | ﹤0.01% |
+19,153
| New | +$45.1K |
|
|
ABVE
2183
DELISTED
Above Food Ingredients Inc
ABVE
| $47.4K | ﹤0.01% |
+27,217
| New | +$47.9K |
|
2184
MicroSectors Gold Miners -3x Inverse Leveraged ETN
GDXD
$1.28B
| $47.3K | ﹤0.01% |
273
+170
| +165% | +$72K |
|
2185
Adicet Bio
ACET
$76.7M
| $47.1K | ﹤0.01% |
3,634
+2,160
| +147% | +$25.4K |
|
|
BHR
2186
Braemar Hotels & Resorts
BHR
$160M
| $46.8K | ﹤0.01% |
+17,143
| New | +$43.3K |
|
|
TGE
2187
The Generation Essentials Group
TGE
$41.7M
| $46.5K | ﹤0.01% |
+21,723
| New | +$92.4K |
|
2188
CalciMedica
CALC
$11.3M
| $46.3K | ﹤0.01% |
+15,345
| New | +$44.1K |
|
2189
Zedge
ZDGE
$38.4M
| $46.3K | ﹤0.01% |
+15,911
| New | +$56.4K |
|
2190
Apyx Medical
APYX
$163M
| $46.1K | ﹤0.01% |
+21,545
| New | +$45.6K |
|
2191
SurgePays
SURG
$6.03M
| $45.5K | ﹤0.01% |
16,193
-23,813
| -60% | -$67.5K |
|
2192
Beam Global
BEEM
$23.1M
| $44.7K | ﹤0.01% |
+15,532
| New | +$37.7K |
|
2193
Enlivex Ltd
ENLV
$37.7M
| $44.4K | ﹤0.01% |
+2,845
| New | +$51.3K |
|
|
MGF
2194
Aberdeen Government Markets Income Fund
MGF
$91.9M
| $44.3K | ﹤0.01% |
+14,200
| New | +$43.9K |
|
|
ICG
2195
Intchains Group
ICG
$47.1M
| $44.1K | ﹤0.01% |
+25,965
| New | +$58.7K |
|
2196
Hongli Group Inc. Class A Ordinary Shares
HLP
$95.7M
| $43.8K | ﹤0.01% |
+32,950
| New | +$25.1K |
|
|
EONR
2197
EON Resources
EONR
$24M
| $43.2K | ﹤0.01% |
88,570
+78,239
| +757% | +$28.4K |
|
2198
Traeger
COOK
$164M
| $43.1K | ﹤0.01% |
707
+45
| +7% | +$3.44K |
|
2199
Kartoon Studios
TOON
$34.8M
| $43.1K | ﹤0.01% |
58,451
+10,253
| +21% | +$7.69K |
|
|
CURR
2200
Currenc Group
CURR
$346M
| $42.7K | ﹤0.01% |
+25,283
| New | +$42.8K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q3 2025 Portfolio in Review
As of Q3 2025, XTX Topco held 3,496 positions worth $1.93B, down 20% from $2.41B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco withdrew a net $562M in Q3 2025, closing 1,006 positions and reducing 717 holdings. Its most notable exit was T-Mobile US, an estimated $9.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, XTX Topco opened a new position in Johnson & Johnson worth $11.3M.
- XTX Topco's largest Q3 2025 buy was Johnson & Johnson: 60,929 shares worth $11.3M.
- XTX Topco added most to Invesco QQQ Trust in Q3 2025, an estimated $7.33M increase.
- XTX Topco's biggest Q3 2025 reduction was Oracle, cutting an estimated $16.2M.
- XTX Topco fully exited T-Mobile US in Q3 2025, selling an estimated $9.81M.
- XTX Topco's ten largest holdings make up 5.5% of its $1.93B portfolio in Q3 2025.
- XTX Topco opened 1,220 new positions and closed 1,006 in Q3 2025.
- XTX Topco's portfolio value fell 20% quarter-over-quarter to $1.93B.
Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.